Improving Efficacy, Minimizing Toxicity in Chemotherapy For Breast Cancer Alex Biese January 22nd 2025 An expert spoke with CURE about providers’ “two-fold goal” when using chemotherapy to treat patients with breast cancer. Watch Kate, Princess of Wales, ‘Got So Attached’ to Her Port During...
NE-diff is increasingly recognized as a mechanism of acquired resistance to targeted therapies in many cancers. Detection of NE-diff is clinically important because high-grade neuroendocrine tumors often respond to platinum-based chemotherapy, but spatial heterogeneity and sampling error make the pathologi...
Effect of neoadjuvant chemotherapy on CD14 + CD16 + monocytes and soluble CD163 in Egyptian breast cancer patients Sara Youssry ,Hossam Ghoneim &Eman ElAlfy Article 15 February 2025|Open Access Artificial intelligence can extract important features for diagnosing axillary lymph node metastasis...
Postoperative chemotherapy drug perfusion and chemotherapy are important means for the treatment of BLCA. However, once d... Authors: Lijie Zhou, Kaixuan Du, Yiheng Dai, Youmiao Zeng, Yongbo Luo, Mengda Ren, Wenbang Pan, Yuanhao Liu, Lailai Zhang, Ronghui Zhu, Dapeng Feng, Fengyan Tian ...
[73,95,96]. However, some research suggests that there may not be a significant difference in CTC counts between blood samples collected before and after chemotherapy, possibly due to variations in CTC identification and treatment strategies [29,93,197]. In addition to quantitative analyses, the...
Patients with metastatic cancers can no longer be cured by local therapy alone and usually die after painful chemotherapy. Thus control of cancer metastasis is an important issue in tumor treatment. Angiogenesis, the process of new blood vessel formation, plays a crucial role in the growth and ...
Chemotherapy is indicated for patients with unresectable or recurrent disease, or those after non-curative R2 resection, whose general condition and major organ functions are preserved: to be specific, patients of PS 0–2, with unresectable T4b disease, extensive nodal disease, hepatic metastases, ...
None of the patients had received chemotherapy or radiation therapy prior to surgery. The depth of tumor invasion, histological grade and status of lymph node metastasis were obtained from histopathological reports. The staging of CRC was classified using the seventh edition of the International Union...
Chemotherapy combined with immunotherapy has improved the treatment of certain solid tumors, but effective regimens remain elusive for pancreatic ductal adenocarcinoma (PDAC). We conducted a randomized phase 2 trial evaluating the efficacy of nivolumab (
Patients who had received previous adjuvant or neoadjuvant chemotherapy were eligible if the last treatment was at least 6 months before randomization. Any PD-L1 immunohistochemistry status was eligible, and tumor PD-L1 expression (on tumor cells or tumor-infiltrating immune cells) was assessed in ...